Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;23(1):4-15.
doi: 10.1111/hiv.13169. Epub 2021 Sep 15.

Same-day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review

Rachael M Burke  1   2 , Hannah M Rickman  1 , Vindi Singh  3   4 , Thokozani Kalua  5 , Niklaus D Labhardt  6   7   8 , Mina Hosseinipour  9   10 , Robert J Wilkinson  11   12   13 , Peter MacPherson  1   2   14
Affiliations
Free article

Same-day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review

Rachael M Burke et al. HIV Med. 2022 Jan.
Free article

Abstract

Objectives: Tuberculosis symptoms are very common among people living with HIV (PLHIV) initiating antiretroviral therapy (ART), are not specific for tuberculosis disease and may result in delayed ART start. The risks and benefits of same-day ART initiation in PLHIV with tuberculosis symptoms are unknown.

Methods: We systematically reviewed nine databases on 12 March 2020 to identify studies that investigated same-day ART initiation among PLHIV with tuberculosis symptoms and reported both their approach to TB screening and clinical outcomes. We extracted and summarized data about TB screening, numbers of people starting same-day ART and outcomes.

Results: We included four studies. Two studies deferred ART for everyone with any tuberculosis symptoms (one or more of cough, fever, night sweats or weight loss) and substantial numbers of people had deferred ART start (28% and 39% did not start same-day ART). Two studies permitted some people with tuberculosis symptoms to start same-day ART, and fewer people deferred ART (2% and 16% did not start same-day). Two of the four studies were conducted sequentially; proven viral load suppression at 8 months was 31% when everyone with tuberculosis symptoms had ART deferred, and 44% when the algorithm was changed so that some people with tuberculosis symptoms could start same-day ART.

Conclusions: Although tuberculosis symptoms are very common in people starting ART, there is insufficient evidence about whether presence of tuberculosis symptoms should lead to ART start being deferred or not. Research to inform clear guidelines would help to maximise the benefits of same-day ART.

Keywords: HIV; guidelines; same-day ART; tuberculosis; tuberculosis screening.

PubMed Disclaimer

References

REFERENCES

    1. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. New Engl J Med. 2015;373(9):795-807.
    1. Ford N, Migone C, Calmy A, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS 2018;32(1):17-23.
    1. WHO | Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy [Internet]. WHO. Cited September 10, 2019. http://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en/
    1. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 2015;29(15):1987-2002.
    1. Post FA, Szubert AJ, Prendergast AJ, et al. Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial. Clin Infect Dis 2018;66(suppl_2):S132-S139.

Publication types